NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility

NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million